Awards & Recognition
★Mentioned Scholastic Silver Key award (mentioned in LinkedIn)
★Recognition through board appointments to multiple public companies
Notable Facts
→EVP and Chief Legal Officer at Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) since 2016
→Serves on multiple public company boards including Evolus Inc and Tenaya Therapeutics
→Board member of Alliance for Regenerative Medicine (ARM)
→Harvard Law School graduate with biology degree from Miami University magna cum laude
→Previously VP Associate General Counsel at Allergan for 11 years
→Former attorney at prestigious law firm Latham & Watkins LLP
→Over 20 years of executive leadership experience in biotech and pharmaceutical industry
→Launched GCs United platform for general counsels
→Owns approximately $3 million in Ultragenyx stock holdings
→Active in rare disease advocacy and policy discussions